Dolutegravir/lamivudine
Dolutegravir/lamivudine was dispensed in England in April 2026, with 1 items, little changed on a year earlier.
Dispensed in April 2026
Rolling 12 months
Net ingredient cost · April 2026
Figure 1. Dolutegravir/lamivudine: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
Embed this chart
Free to reuse with the credit line above.
At a glance
- Therapeutic class Antiviral drugs
- Presentations 1 shown
- Average cost / item £656.26
- Year on year Little changed on a year earlier
Top presentations, April 2026
The individual products dispensed under Dolutegravir/lamivudine this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Dovato 50mg/300mg tablets | 0503010AUBBAAAA | 1 | £656 |
Source: NHSBSA Prescription Cost Analysis · to April 2026 OGL v3.0
Where Dolutegravir/lamivudine is dispensed
The regions and dispensing practices with the highest Dolutegravir/lamivudine volumes.
Top regions
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Dolutegravir/lamivudine with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Dolutegravir/lamivudine is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.